Andy Batts
Long only, value, growth, momentum

CircuLite Boosts HeartWare's Fundamentals But What About Profit?

Executive summary:

  • HeartWare has acquired CircuLite, maker of SYNERGY Circulatory Support System.
  • At the size of an AA battery, the potential of SYNERGY is huge.
  • SYNERGY would be modified further into a totally endovascular concept.
  • SYNERGY has boosted HeartWare's fundamentals significantly.


HeartWare International (NASDAQ:HTWR) recently announced that it has acquired CircuLite, a company that has pioneered the partial-assist approach of mechanical circulatory support with its SYNERGY Circulatory Support System for the treatment of heart failure for patients who don't respond to traditional therapy and who are not sick enough for inotropes or a full-support bed.

I believe that HeartWare's CircuLite acquisition will tremendously strengthen its product pipeline and strongly complement its HVAD and MVAD product line. Moreover,...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details